On Feb 25, 2013, Atossa Genetics, Inc. (ATOS) received a Warning Letter from the FDA regarding its Mammary Aspirate Specimen Cytology Test (MASCT) System and MASCT System Collection Test. The Letter ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback